DC-based immunotherapy to treat Malignant Mesothelioma

Project Information

H2020MM04

Grant agreement ID: 668769

DOI 10.3030/668769

Project closed

EC signature date 1 December 2015

Start date 1 January 2016

End date 31 December 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 782 965,00

EU contribution € 5 782 965,00

Coordinated by

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands